Orlando, FL -- (SBWIRE) -- 10/10/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN).
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock dropped 4.26% to $4.27. Cowen and Company assumed coverage on shares of ARNA in a report released on Oct. 7. The firm issued a market perform rating and a $4.50 price objective on the stock. Separately, ARNA’s stocks price target lowered to $4 from $5 at Credit Suisse on Sept. 30.
Additionally, the company announced that the company was scheduled to present a corporate overview, including a BELVIQ(®) (lorcaserin HCl) CIV launch update, at the NewsMakers in the Biotech Industry conference on Friday, September 27, 2013, at 11:30 a.m. Eastern Time (8:30 a.m. Pacific Time), at the Millennium Broadway Hotel in New York City.
Are investors worried about the recent updates with ARNA? Find out with a free trend analysis HERE
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares declined 11.13% to $2.43. Glancy Binkow & Goldberg LLP on Oct. 9 announces that it is investigating potential claims on behalf of investors of Achillion Pharmaceuticals, Inc. ("Achillion" or the "Company") (NASDAQ:ACHN) concerning possible violations of federal securities laws. Investors with losses of $250,000 or more are encouraged to contact the firm for more information.
Additionally, the company on Sept. 27 provided an update on development of compounds in its pipeline of therapies for the treatment of chronic hepatitis C virus, or HCV. Achillion received a response from the U. S. Food and Drug Administration, or FDA, on the clinical hold related to sovaprevir, Achillion's NS3 protease inhibitor.
Is ACHN going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)